ERBB3 and head and neck squamous cell carcinoma: Evidence in this respect comes from studies on laryngeal HNSCC in which ErbB3 was primarily observed in the nuclear compartment of tumor cells in association with variable cytoplasmic staining, and low expression levels of the receptor were associated with high proliferative indices, and with shorter relapse-free and overall survival (88, 91).